Home Cart 0 Sign in  

[ CAS No. 74733-27-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 74733-27-0
Chemical Structure| 74733-27-0
Structure of 74733-27-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 74733-27-0 ]

Related Doc. of [ 74733-27-0 ]

Alternatived Products of [ 74733-27-0 ]

Product Details of [ 74733-27-0 ]

CAS No. :74733-27-0 MDL No. :MFCD11976783
Formula : C10H11BrO3 Boiling Point : -
Linear Structure Formula :- InChI Key :DCXFLSHDURQRML-UHFFFAOYSA-N
M.W : 259.10 Pubchem ID :11288398
Synonyms :

Calculated chemistry of [ 74733-27-0 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 57.05
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.03 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.62
Log Po/w (XLOGP3) : 2.6
Log Po/w (WLOGP) : 2.22
Log Po/w (MLOGP) : 2.37
Log Po/w (SILICOS-IT) : 2.75
Consensus Log Po/w : 2.51

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.14
Solubility : 0.189 mg/ml ; 0.000729 mol/l
Class : Soluble
Log S (Ali) : -3.0
Solubility : 0.262 mg/ml ; 0.00101 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.86
Solubility : 0.0356 mg/ml ; 0.000137 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.83

Safety of [ 74733-27-0 ]

Signal Word:Danger Class:8
Precautionary Statements:P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501 UN#:3261
Hazard Statements:H302-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 74733-27-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 74733-27-0 ]
  • Downstream synthetic route of [ 74733-27-0 ]

[ 74733-27-0 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 81245-24-1 ]
  • [ 74733-27-0 ]
YieldReaction ConditionsOperation in experiment
96% With bromine In tetrachloromethane for 1.75 h; Heating / reflux; Irradiation To a refluxing mixture of methyl 2-methoxy-4-methyl-benzoate (21.625 g, 120 mmol) in CC14 (240 mL) was addeddropwise a solution of bromine (6.19 mL, 120 mmol) in CC14(75 mL) over 1.5 h. During the bromine addition thereaction was irradiated with a 250 W tungsten lamp. Afterthe addition, the reaction was refluxed for 15 min andconcentrated, and vacuum pumped to give methyl 2-methoxy-4-(bromomethyl)benzoate as an oil (29.864 g, 96percent)..NMR (400MHz, CDC13): 5 partial 2.40 (s, 3H), 3.87 (s, 3H),3.91 (s, 3H), 4.44 (s, 2H).FIA-MS, m/e: 259 (m+1).
91% With tert.-butylhydroperoxide; cetyltrimethylammonim bromide; potassium bromide In water at 120℃; Microwave irradiation General procedure: The reaction mixture was treated in a controlled microwavesynthesizer (Biotage Initiator+SP Wave model, 0–200 W at2.45 GHz, capped at 60 W during steady state) for severalminutes (the reaction attained 120 °C at 1 bar pressure). Thefinal products were isolated by column chromatographyusing an EtOAc–hexane gradient
48% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethaneReflux; Darkness Stage 1: methyl 4-bromomethyl-2-methoxy-benzoate
To 5.38 g of methyl 2-methoxy-4-methyl benzoate in 20 mL of carbon tetrachloride, are added 5.3 g of N-bromosuccinimide (1 equivalent) and 490 mg of AIBN (0.1 equivalent) away from direct light.
The whole is refluxed by heating overnight.
The reaction medium is evaporated under reduced pressure and then purified on silica gel (petroleum ether/ethyl acetate: 90/10) leading to 3.73 g of the desired product.
Yield: 48percent
1H NMR (CDCl3, 300 MHz) δ (ppm): 7.76 (d, 1H), 6.99 (m, 2H), 4.46 (s, 2H), 3.92 (s, 3H), 3.88 (s, 3H)
27% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane for 2 h; Inert atmosphere Compound 15 (27 mg, 0.1497 mmol) was diluted with 5 mL of CCl 4, and NBS (N-bromosuccinimide, 27 mg, 1.497 mmol) and an AIBN catalytic amount were added to a round bottom flask with two rounds replaced with argon gas, And stirred for 2 hours. After confirming the completion of the reaction, gradually cool to room temperature, and filter using Celite. The residue was subjected to column chromatography (n-hexane: ethyl acetate = 3: 1) to obtain Compound 16 as a transparent liquid. (0.009 g, 27percent).
10 g With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane for 18 h; Reflux To a solution of methyl 2-methoxy-4-methylbenzoate (10.00 g, 55 mmol) in CCl4 (150 mL) were added NBS (1 1.8 g, 66 mmol) and AIBN (0.100 g). The reaction mixture was refluxed for 18 h. The reaction mass was diluted with diethyl ether and washed with 25percent NaOH solution. The organic layer was dried over anhydrous sodium sulphate and concentrated to afford 10.00 g of desired product. 1H NMR (300 MHz, DMSO d6): δ 3.77 (m, 6H), 4.68 (s, 2H), 7.06 (d, J = 7.8 Hz, 1H), 7.23 (s, 1H), 7.61 (d, / = 7.8 Hz, 1H); MS (m/z): 259.13 (M)+.
144 g With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 70℃; for 15 h; Inert atmosphere 3C. Methyl 4-(bromomethyl)-2-methoxy-benzoatestirred solution of methyl 2-methoxy-4-methyl-benzoate (100 g, 555 mmol) and Nbromosuccinimide (108.6 g, 610 mmol) in carbon tetrachloride (1300 mL) wasdegassed with nitrogen for 15 minutes. CL,CL’-Azoisobutyronitrile (18.2 g, 111 mmol) was added in one portion and the resulting mixture heated to 70°C for 15 hours then allowed to cool to room temperature. The mixture was poured into water (600 mL) and then the separated aqueous phase extracted with DCM (2 x 800 mL). The combined organic extracts were dried (Na2SO4) and evaporated under reduced pressure to givethe title compound (144 g) which was used without further purification.

Reference: [1] Patent: WO2004/108677, 2004, A1, . Location in patent: Page 199
[2] Synlett, 2014, vol. 25, # 17, p. 2485 - 2487
[3] Patent: US2009/209586, 2009, A1, . Location in patent: Page/Page column 13
[4] Patent: KR2016/20674, 2016, A, . Location in patent: Paragraph 0053; 0115; 0116
[5] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
[6] Patent: EP2133353, 2009, A1, . Location in patent: Page/Page column 54-55
[7] Patent: US6359134, 2002, B1, . Location in patent: Referential example 28
[8] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 22, p. 6768 - 6778
[9] Patent: WO2013/186692, 2013, A1, . Location in patent: Page/Page column 107; 108
[10] Patent: US2014/163066, 2014, A1, . Location in patent: Paragraph 0313-0314
[11] Patent: WO2015/120390, 2015, A1, . Location in patent: Page/Page column 92; 138; 139
[12] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 2, p. 185 - 190
[13] Patent: US5880147, 1999, A,
[14] Patent: EP2272835, 2011, A1, . Location in patent: Page/Page column 19-20
  • 2
  • [ 50-85-1 ]
  • [ 74733-27-0 ]
Reference: [1] Patent: US6265416, 2001, B1,
[2] Patent: WO2013/186692, 2013, A1,
[3] Patent: WO2015/120390, 2015, A1,
[4] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 2, p. 185 - 190
[5] Patent: EP2272835, 2011, A1,
  • 3
  • [ 81245-24-1 ]
  • [ 74733-27-0 ]
Reference: [1] Patent: US5302601, 1994, A,
  • 4
  • [ 50-85-1 ]
  • [ 74-88-4 ]
  • [ 74733-27-0 ]
Reference: [1] Patent: US6359136, 2002, B1, . Location in patent: Example 1C
  • 5
  • [ 128-08-5 ]
  • [ 81245-24-1 ]
  • [ 74733-27-0 ]
Reference: [1] Patent: US4478849, 1984, A,
  • 6
  • [ 4670-56-8 ]
  • [ 74733-27-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 22, p. 6768 - 6778
[2] Patent: WO2015/120390, 2015, A1,
[3] Patent: KR2016/20674, 2016, A,
  • 7
  • [ 122-46-3 ]
  • [ 74733-27-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
[2] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
  • 8
  • [ 35633-35-3 ]
  • [ 74733-27-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
[2] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
  • 9
  • [ 704-45-0 ]
  • [ 74733-27-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
[2] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
  • 10
  • [ 81245-24-1 ]
  • [ 74733-27-0 ]
  • [ 186697-31-4 ]
Reference: [1] Bioorganic and medicinal chemistry, 2002, vol. 10, # 9, p. 3013 - 3021
  • 11
  • [ 67-56-1 ]
  • [ 88709-30-2 ]
  • [ 74733-27-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1962, p. 2255 - 2261
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 74733-27-0 ]

Aryls

Chemical Structure| 70264-94-7

[ 70264-94-7 ]

Methyl 4-(bromomethyl)-3-methoxybenzoate

Similarity: 0.95

Chemical Structure| 142031-88-7

[ 142031-88-7 ]

Methyl 3-(bromomethyl)-4-methoxybenzoate

Similarity: 0.93

Chemical Structure| 39503-58-7

[ 39503-58-7 ]

Methyl 5-bromo-2-methoxy-4-methylbenzoate

Similarity: 0.87

Chemical Structure| 788081-99-2

[ 788081-99-2 ]

Methyl 2-(bromomethyl)-5-methoxybenzoate

Similarity: 0.87

Chemical Structure| 15365-25-0

[ 15365-25-0 ]

Methyl 2-(bromomethyl)-4-methoxybenzoate

Similarity: 0.87

Bromides

Chemical Structure| 70264-94-7

[ 70264-94-7 ]

Methyl 4-(bromomethyl)-3-methoxybenzoate

Similarity: 0.95

Chemical Structure| 142031-88-7

[ 142031-88-7 ]

Methyl 3-(bromomethyl)-4-methoxybenzoate

Similarity: 0.93

Chemical Structure| 39503-58-7

[ 39503-58-7 ]

Methyl 5-bromo-2-methoxy-4-methylbenzoate

Similarity: 0.87

Chemical Structure| 788081-99-2

[ 788081-99-2 ]

Methyl 2-(bromomethyl)-5-methoxybenzoate

Similarity: 0.87

Chemical Structure| 15365-25-0

[ 15365-25-0 ]

Methyl 2-(bromomethyl)-4-methoxybenzoate

Similarity: 0.87

Ethers

Chemical Structure| 70264-94-7

[ 70264-94-7 ]

Methyl 4-(bromomethyl)-3-methoxybenzoate

Similarity: 0.95

Chemical Structure| 142031-88-7

[ 142031-88-7 ]

Methyl 3-(bromomethyl)-4-methoxybenzoate

Similarity: 0.93

Chemical Structure| 39503-58-7

[ 39503-58-7 ]

Methyl 5-bromo-2-methoxy-4-methylbenzoate

Similarity: 0.87

Chemical Structure| 788081-99-2

[ 788081-99-2 ]

Methyl 2-(bromomethyl)-5-methoxybenzoate

Similarity: 0.87

Chemical Structure| 15365-25-0

[ 15365-25-0 ]

Methyl 2-(bromomethyl)-4-methoxybenzoate

Similarity: 0.87

Esters

Chemical Structure| 70264-94-7

[ 70264-94-7 ]

Methyl 4-(bromomethyl)-3-methoxybenzoate

Similarity: 0.95

Chemical Structure| 142031-88-7

[ 142031-88-7 ]

Methyl 3-(bromomethyl)-4-methoxybenzoate

Similarity: 0.93

Chemical Structure| 39503-58-7

[ 39503-58-7 ]

Methyl 5-bromo-2-methoxy-4-methylbenzoate

Similarity: 0.87

Chemical Structure| 788081-99-2

[ 788081-99-2 ]

Methyl 2-(bromomethyl)-5-methoxybenzoate

Similarity: 0.87

Chemical Structure| 15365-25-0

[ 15365-25-0 ]

Methyl 2-(bromomethyl)-4-methoxybenzoate

Similarity: 0.87

Benzyl Bromides

Chemical Structure| 70264-94-7

[ 70264-94-7 ]

Methyl 4-(bromomethyl)-3-methoxybenzoate

Similarity: 0.95

Chemical Structure| 142031-88-7

[ 142031-88-7 ]

Methyl 3-(bromomethyl)-4-methoxybenzoate

Similarity: 0.93

Chemical Structure| 788081-99-2

[ 788081-99-2 ]

Methyl 2-(bromomethyl)-5-methoxybenzoate

Similarity: 0.87

Chemical Structure| 15365-25-0

[ 15365-25-0 ]

Methyl 2-(bromomethyl)-4-methoxybenzoate

Similarity: 0.87

Chemical Structure| 71887-28-0

[ 71887-28-0 ]

Methyl 2-(bromomethyl)-3-methoxybenzoate

Similarity: 0.85